Ovarian stimulation drugs alter the metabolite content of the growing follicle: in vivo spectroscopic evaluation of follicle fluid

OBJECTIVE: To determine and compare metabolite content using magnetic resonance spectroscopy (MRS) of growing follicles in patients with polycystic ovary syndrome (PCOS) receiving recombinant follicle stimulating hormone (rFSH), clomiphene citrate (CC) or aromatase inhibitor (AI) for ovarian stimula...

Descripción completa

Detalles Bibliográficos
Autores principales: Dokuzeylül Güngör, Nur, Güngör, Kağan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187978/
https://www.ncbi.nlm.nih.gov/pubmed/33389923
http://dx.doi.org/10.4274/jtgga.galenos.2020.2020.0104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187978/
https://www.ncbi.nlm.nih.gov/pubmed/33389923
http://dx.doi.org/10.4274/jtgga.galenos.2020.2020.0104

Ejemplares similares